Skip to main content
SpringerLink
Log in

Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The pretreatment bone scintigrams of 58 patients with prostate cancer with bone metastasis were reviewed and the prognostic value of the initial extent of bone involvement was compared with that of other pretreatment characteristics.

The extent of bone metastasis revealed by the scan was related to survival. The serum level of alkaline phosphatase at pretreatment and pathological grade also had some predictive value. Although the pathological grade of primary tumours was related to prognosis, the survival of patients with the same histological grade differed according to the initial extent of disease, patients with extensive disease along with raised serum alkaline phosphatase (twice or more as high as the cut-off value) had poorer prognosis than did those with lower alkaline phosphatase or smaller extent of disease. The extent of bone involvement in combination with serum alkaline phosphatase level therefore apparently has higher prognostic value than does disease extent alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blackard, C. E., Byar, D. P., Jordan, W. P.: Orchiectomy for advanced prostatic carcinoma: A re-evaluation.Urology, 1, 553 (1973).

    Article  PubMed  CAS  Google Scholar 

  2. Böcking, A., Sinagowitz, E.: Histologic grading of prostatic carcinoma.Path. Res. Pract., 168, 115 (1980).

    PubMed  Google Scholar 

  3. Brendler, C. B., Isaacs, J. T., Follansbee, A. L., Walsh, P. C.: The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: A preliminary report.J. Urol., 131, 694 (1984).

    PubMed  CAS  Google Scholar 

  4. Byar, D. P., Huse, R., Bailar, J. C. III, The Veterans Administration Cooperative Urological Research Group: An exponential model relating censored survival data and concomitant information for prostatic cancer patients.J. Natl. Cancer Inst., 52, 321 (1974).

    PubMed  CAS  Google Scholar 

  5. Catalona, W., Scott, W. W.: Campbell's Urology. Saunders, Philadelphia 1986.

    Google Scholar 

  6. Drelichman, A., Decker, D. A., Al-Sarraf, M., Vaitkevicius, V. K., Muz, J.: Computerized bone scan: A potentially useful technique to measure response in prostatic carcinoma.Cancer, 53, 1061 (1984).

    Article  PubMed  CAS  Google Scholar 

  7. Gleason, D. F., Mellingen, G. T., The Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.J. Urol., 111, 58 (1974).

    PubMed  CAS  Google Scholar 

  8. Heller, J. E.: Prostatic acid phosphatase: Its current clinical status.J. Urol., 137, 1091 (1987).

    PubMed  CAS  Google Scholar 

  9. Hovsepian, J. A., Byar, D. P., The Veterans Administration Cooperative Urological Research Group: Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma.Urology, 14, 145 (1979).

    Article  PubMed  CAS  Google Scholar 

  10. Japanese Urological Association & Japanese Pathological Society: General rule for clinical and pathological studies on prostatic cancer.Kanehara, Tokyo 1985.

    Google Scholar 

  11. Killian, C. S., Vargas, F. P., Slack, N. H., Murphy, G. P., Chu, T. P.: Prostate-specific antigen versus acid phosphatase in monitoring patients with prostate cancer.Ann. N.Y. Acad. Sci., 390, 122 (1980).

    Article  Google Scholar 

  12. Knudson, G., Grinis, G., Lopez-Majano, V., Sansi, P., Targonski, P., Rubenstein, M., Sharifi, R., Guinan, P.: Bone scan as a stratification variable in advanced prostate cancer.Cancer, 68, 316 (1991).

    Article  PubMed  CAS  Google Scholar 

  13. Kumamoto, Y., Tsukamoto, T., Umehara, T., Harada, M., Shimazaki, J., Fuse, H., Oshima, H., Takeuchi, H., Yoshida, O., Okada, K., Saito, Y., Kanetake, H., Tamiya, T.: Clinical studies on endocrine therapy for prostate carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis.Acta Urol. Jpn., 36, 295 (1990).

    CAS  Google Scholar 

  14. McCrea, L. E., Karafin, L.: Carcinoma of the prostate: Metastases, therapy, and survival. A statistical analysis of 500 cases.Int. Coll. Surg. J., 29, 723 (1958).

    CAS  Google Scholar 

  15. Paulson, D. F.: Principles and management of Urologic Cancer. Williams & Wilkins, Baltimore-London 1983.

    Google Scholar 

  16. Schroeder, F. H., Blom, J. H. M., Hop, W. C. J., Mostofi, F. K.: Grading of prostatic cancer (1): An analysis of the prognostic significance of single characteristics.The Prostate, 6, 81 (1985).

    PubMed  CAS  Google Scholar 

  17. Shimazaki, J., Fuse, H., Zama, S.: Endocrine therapy for prostatic cancer.Jap. J. Cancer Clin., 31, 1195 (1985).

    CAS  Google Scholar 

  18. Sogani, P. C., Israel, A., Lieberman, P. H., Lesser, M. L., Whitmore, W. F. Jr.: Gleason grading of prostate cancer: A predictor of survival.Urology, 25, 223 (1985).

    Article  PubMed  CAS  Google Scholar 

  19. Soloway, M. S., Hardeman, S. W., Hickey, D., Raymond, J., Todd, B., Soloway, S., Moinuddin, M.: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.Cancer, 61, 195 (1988).

    Article  PubMed  CAS  Google Scholar 

  20. Wilson, D. W., Harper, M. E., Jensen, H. M., Ikeda, R. M., Richards, G., Peeling, W. B., Pierrepoint, C. G., Griffiths, K.: A prognostic index for the clinical management of patients with advanced prostatic cancer: A British Study Group investigation.The Prostate, 7, 131 (1985).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

    H. Fuse, I. Mizuno, T. Yokoyama, M. Sakamoto & T. Katayama

Authors
  1. H. Fuse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Mizuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Katayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuse, H., Mizuno, I., Yokoyama, T. et al. Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy. International Urology and Nephrology 27, 567–574 (1995). https://doi.org/10.1007/BF02564743

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02564743

Keywords

Search

Navigation